FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney diseaseResearch in context
Background: Tubulointerstitial fibrosis (TIF) plays an important role in the progression of diabetic kidney disease (DKD). Forkhead box O1 (FoxO1) is involved in the regulation of metabolism and cell apoptosis, but its function in renal TIF induced by DKD is less well understood. Methods: Human kidn...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-10-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396419306000 |
id |
doaj-5edf037ee2e94d4f80c91447c09c2323 |
---|---|
record_format |
Article |
spelling |
doaj-5edf037ee2e94d4f80c91447c09c23232020-11-24T21:39:28ZengElsevierEBioMedicine2352-39642019-10-0148491504FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney diseaseResearch in contextFengjuan Huang0Qingzhu Wang1Feng Guo2Yanyan Zhao3Linlin Ji4Tingting An5Yi Song6Yang Liu7Yanyan He8Guijun Qin9Division of Endocrinology, Department of Internal Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China; Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, ChinaDivision of Endocrinology, Department of Internal Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, ChinaDivision of Endocrinology, Department of Internal Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, ChinaDivision of Endocrinology, Department of Internal Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, ChinaInstitute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, ChinaInstitute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, ChinaInstitute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, ChinaInstitute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, ChinaInstitute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, ChinaDivision of Endocrinology, Department of Internal Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China; Corresponding author at: Division of Endocrinology, Department of Internal Medicine, The First Affiliated Hospital of Zhengzhou University, 40 Daxue Road, Zhengzhou 450052, China.Background: Tubulointerstitial fibrosis (TIF) plays an important role in the progression of diabetic kidney disease (DKD). Forkhead box O1 (FoxO1) is involved in the regulation of metabolism and cell apoptosis, but its function in renal TIF induced by DKD is less well understood. Methods: Human kidney biopsies with DKD and normal controls were used to detect apoptosis and TIF induced by diabetes. A mouse model with kidney-specific overexpression of Pax2-3aFoxO1 was established to further investigate the functions of FoxO1 in vivo. The in vitro roles of FoxO1 were analyzed in HK-2 cells with 3aFoxO1-knockin (3aFoxO1-KI) or FoxO1-knockdown (FoxO1-KD) via CRISPR/Cas9. Western blot, immunohistochemistry, and chromatin immunoprecipitation were used to explore the underlying mechanisms. Findings: In this study, DKD patients had increased renal TIF and apoptosis. In vivo study showed that kidney-specific overexpression of Pax2-3aFoxO1 significantly reduced the expression of p-STAT1 with resultant renal functional impairment, retarding renal TIF and apoptosis in diabetic mice. Meanwhile, We observed that FoxO1-KD in HK-2 cells aggravated the expression of p-STAT1, leading to activation of epithelial-to-mesenchymal transition (EMT) and intrinsic apoptotic pathway. Conversely, EMT and apoptosis were significantly attenuated in HK-2 cells with 3aFoxO1-KI under hyperglycemic conditions. Interpretation: Taken together, these data suggest that the protection role of FoxO1 against renal TIF and apoptosis in DKD is likely in part to target STAT1 signaling, which may be a promising strategy for long-term treatment of DKD. Fund: This work was supported by grants from the National Natural Science Foundation of China (grant numbers: 81570746 and 81770812). Keywords: FoxO1, STAT1, Apoptosis, Diabetic kidney disease, Tubulointerstitial fibrosishttp://www.sciencedirect.com/science/article/pii/S2352396419306000 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Fengjuan Huang Qingzhu Wang Feng Guo Yanyan Zhao Linlin Ji Tingting An Yi Song Yang Liu Yanyan He Guijun Qin |
spellingShingle |
Fengjuan Huang Qingzhu Wang Feng Guo Yanyan Zhao Linlin Ji Tingting An Yi Song Yang Liu Yanyan He Guijun Qin FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney diseaseResearch in context EBioMedicine |
author_facet |
Fengjuan Huang Qingzhu Wang Feng Guo Yanyan Zhao Linlin Ji Tingting An Yi Song Yang Liu Yanyan He Guijun Qin |
author_sort |
Fengjuan Huang |
title |
FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney diseaseResearch in context |
title_short |
FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney diseaseResearch in context |
title_full |
FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney diseaseResearch in context |
title_fullStr |
FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney diseaseResearch in context |
title_full_unstemmed |
FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney diseaseResearch in context |
title_sort |
foxo1-mediated inhibition of stat1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney diseaseresearch in context |
publisher |
Elsevier |
series |
EBioMedicine |
issn |
2352-3964 |
publishDate |
2019-10-01 |
description |
Background: Tubulointerstitial fibrosis (TIF) plays an important role in the progression of diabetic kidney disease (DKD). Forkhead box O1 (FoxO1) is involved in the regulation of metabolism and cell apoptosis, but its function in renal TIF induced by DKD is less well understood. Methods: Human kidney biopsies with DKD and normal controls were used to detect apoptosis and TIF induced by diabetes. A mouse model with kidney-specific overexpression of Pax2-3aFoxO1 was established to further investigate the functions of FoxO1 in vivo. The in vitro roles of FoxO1 were analyzed in HK-2 cells with 3aFoxO1-knockin (3aFoxO1-KI) or FoxO1-knockdown (FoxO1-KD) via CRISPR/Cas9. Western blot, immunohistochemistry, and chromatin immunoprecipitation were used to explore the underlying mechanisms. Findings: In this study, DKD patients had increased renal TIF and apoptosis. In vivo study showed that kidney-specific overexpression of Pax2-3aFoxO1 significantly reduced the expression of p-STAT1 with resultant renal functional impairment, retarding renal TIF and apoptosis in diabetic mice. Meanwhile, We observed that FoxO1-KD in HK-2 cells aggravated the expression of p-STAT1, leading to activation of epithelial-to-mesenchymal transition (EMT) and intrinsic apoptotic pathway. Conversely, EMT and apoptosis were significantly attenuated in HK-2 cells with 3aFoxO1-KI under hyperglycemic conditions. Interpretation: Taken together, these data suggest that the protection role of FoxO1 against renal TIF and apoptosis in DKD is likely in part to target STAT1 signaling, which may be a promising strategy for long-term treatment of DKD. Fund: This work was supported by grants from the National Natural Science Foundation of China (grant numbers: 81570746 and 81770812). Keywords: FoxO1, STAT1, Apoptosis, Diabetic kidney disease, Tubulointerstitial fibrosis |
url |
http://www.sciencedirect.com/science/article/pii/S2352396419306000 |
work_keys_str_mv |
AT fengjuanhuang foxo1mediatedinhibitionofstat1alleviatestubulointerstitialfibrosisandtubuleapoptosisindiabetickidneydiseaseresearchincontext AT qingzhuwang foxo1mediatedinhibitionofstat1alleviatestubulointerstitialfibrosisandtubuleapoptosisindiabetickidneydiseaseresearchincontext AT fengguo foxo1mediatedinhibitionofstat1alleviatestubulointerstitialfibrosisandtubuleapoptosisindiabetickidneydiseaseresearchincontext AT yanyanzhao foxo1mediatedinhibitionofstat1alleviatestubulointerstitialfibrosisandtubuleapoptosisindiabetickidneydiseaseresearchincontext AT linlinji foxo1mediatedinhibitionofstat1alleviatestubulointerstitialfibrosisandtubuleapoptosisindiabetickidneydiseaseresearchincontext AT tingtingan foxo1mediatedinhibitionofstat1alleviatestubulointerstitialfibrosisandtubuleapoptosisindiabetickidneydiseaseresearchincontext AT yisong foxo1mediatedinhibitionofstat1alleviatestubulointerstitialfibrosisandtubuleapoptosisindiabetickidneydiseaseresearchincontext AT yangliu foxo1mediatedinhibitionofstat1alleviatestubulointerstitialfibrosisandtubuleapoptosisindiabetickidneydiseaseresearchincontext AT yanyanhe foxo1mediatedinhibitionofstat1alleviatestubulointerstitialfibrosisandtubuleapoptosisindiabetickidneydiseaseresearchincontext AT guijunqin foxo1mediatedinhibitionofstat1alleviatestubulointerstitialfibrosisandtubuleapoptosisindiabetickidneydiseaseresearchincontext |
_version_ |
1725931194538786816 |